- Overview
- Bayer Group
- Stock
- Debt
- Reports
- Annual Stockholders’ Meeting 2020
- Events
- Inside Information
- Latest Inside Information
- Archive Overview
- Inside Information 2019
- Inside Information 2018
- Inside Information 2017
- Ad-hoc 2016
- Ad-hoc 2015
- Ad-hoc 2014
- Ad-hoc 2013
- Ad-hoc 2012
- Ad-hoc 2011
- Ad-hoc 2010
- Ad-hoc 2009
- Ad-hoc 2008
- Ad-hoc 2007
- Ad-hoc 2006
- Ad-hoc 2005
- Ad-hoc 2004
- Ad-hoc 2003
- Ad-hoc 2002
- Ad-hoc 2001
- Ad-hoc 2000
- Ad-hoc 1999
- Ad-hoc 1998
- News
- Investor News
- Press
- Archive
- Overview
- Investor News 2019
- Investor News 2018
- Investor News 2017
- Investor News 2016
- Investor News 2015
- Investor News 2014
- Investor News 2013
- Investor News 2012
- Investor News 2011
- Investor News 2010
- Investor News 2009
- Investor News 2008
- Investor News 2007
- Investor News 2006
- Investor News 2005
- Investor News 2004
- Investor News 2003
- Investor News 2002
- Investor News 2001
- Investor News 2000
- Handouts
- Downloads
- Service
Q3 2012 Investor Conference Call
Tuesday, October 30, 2012
Start at approx. 2:00 p.m. CET (1:00 p.m. GMT)
Third quarter of 2012:
Bayer on track for a successful 2012
Upward trend at HealthCare and CropScience continues / Sales advanced by 11.5 percent to EUR 9,665 million / EBIT of EUR 838 million (minus 23.7 percent) / EBITDA before special items improved by 2.2 percent to EUR 1,845 million / Net income of EUR 528 million (minus 17.8 percent) / Further progress with innovation pipeline / Group forecast for 2012 confirmed more
MP3 audio recording (presentation and discussion)
| Presentation charts for conference call | Download PDF collect (403 KB) |
| Financial Report as of September 30, 2012 | Download PDF collect (2 MB) |
| Q3 2012 Analyst and Investor Briefing | Download PDF collect (338 KB) |
| Transcript | Download PDF collect (409 KB) |
| Q3 2012 All in One Package for Investors and Analysts All documents in one ZIP file | Download ZIP collect (3 MB) |